Integrated medicament delivery device for use with continuous analyte sensor
First Claim
1. An integrated system for monitoring and treating diabetes, the system comprising:
- a medicament injection pen configured and arranged for injecting an amount of a medicament into a host;
an integrated receiver configured and arranged to receive sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration of the host in vivo, wherein the integrated receiver comprises electronics configured and arranged to process the sensor data to calculate at least one of time of medicament therapy and amount of medicament therapy, and wherein the integrated electronics are configured and arranged to require validation of the calculated at least one of time of medicament therapy and amount of medicament therapy, when an evaluation step determines a potential risk is present, prior to injecting an amount of medicament into the host, anda user interface configured and arranged for at least input of host information, wherein the user interface is further configured to display a graphical representation of at least sensor data and medicament delivery data, wherein the user interface further displays at least one of a target glucose concentration or a range.
1 Assignment
0 Petitions
Accused Products
Abstract
An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
-
Citations
21 Claims
-
1. An integrated system for monitoring and treating diabetes, the system comprising:
-
a medicament injection pen configured and arranged for injecting an amount of a medicament into a host; an integrated receiver configured and arranged to receive sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration of the host in vivo, wherein the integrated receiver comprises electronics configured and arranged to process the sensor data to calculate at least one of time of medicament therapy and amount of medicament therapy, and wherein the integrated electronics are configured and arranged to require validation of the calculated at least one of time of medicament therapy and amount of medicament therapy, when an evaluation step determines a potential risk is present, prior to injecting an amount of medicament into the host, and a user interface configured and arranged for at least input of host information, wherein the user interface is further configured to display a graphical representation of at least sensor data and medicament delivery data, wherein the user interface further displays at least one of a target glucose concentration or a range. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. An integrated system for monitoring and treating diabetes, the system comprising:
-
a receiver configured and arranged to receive sensor data from an operably connected continuous glucose sensor, wherein the continuous glucose sensor is configured and arranged to generate sensor data associated with a glucose concentration of a host, wherein the receiver includes a user interface configured and arranged for at least input of host information, wherein the user interface is further configured to display a graphical representation of at least sensor data and medicament delivery data, wherein the user interface further displays at least one of a target glucose concentration or a range; integrated electronics configured to process the sensor data and to generate a medicament therapy, including to calculate at least one of time of medicament therapy and amount of medicament therapy, and wherein the integrated electronics are further configured and arranged to require validation of the calculated at least one of time of medicament therapy and amount of medicament therapy, when an evaluation step determines a potential risk is present, prior to injecting an amount of medicament into the host; and a medicament injection pen configured to inject an amount of medicament into the host.
-
Specification